PLASMA IMMOBILIZATION OF BACTERIOPHAGES AND APPLICATIONS THEREOF
A medical device, the medical device including a substrate defining a surface; a plasma polymer layer bound to and coating the surface; and a bactericide layer bound to the plasma polymer layer, the plasma polymer layer being between the substrate and the bactericide layer. Also, a method for coating a surface of a substrate of a medical device with a bactericide layer, the method including: exposing the surface to a plasma to form a plasma polymer layer bound to the surface; and binding a bactericide layer to the plasma polymer layer.
1 . A medical device, the medical device comprising:
a substrate defining a surface;
a plasma polymer layer bound to and coating the surface; and
a bactericide layer bound to the plasma polymer layer, the plasma polymer layer being between the substrate and the bactericide layer.
2 . The medical device as defined in claim 1 , wherein the bactericide layer includes bioactive bacteriophages.
3 . The medical device as defined in claim 1 , wherein the bactericide layer includes bacteriophage related products selected from the group consisting of endolysins, lysostaphins, phage proteins, phage enzymatic formulations, and combinations thereof.
4 . The medical device as defined in claim 1 , wherein the bactericide layer further includes a bioactive agent selected from the group consisting of antibiotics, a cell adhesion promoting agents, an antithrombic factors, antiseptics, anti-infectives, antibiotics, pain relievers, antibacterials, antiprotozoal agents, antiviral agents, analgesics, anti-inflammatory agents, contraceptives, CNS active drugs, hormones, enzymes, hemostatics, and vaccines.
5 . (canceled)
6 . (canceled)
7 . The medical device as defined in claim 5 wherein the substrate is essentially made of titanium.
8 . The medical device as defined in claim 5 , wherein the substrate includes at least one of a polymer, iron, copper, zinc, lead, aluminum, titanium, gold, platinum, silver, cobalt, chromium, vanadium, tantalum, nickel, magnesium, manganese, cobalt chrome, nickel titanium, titanium vanadium aluminum, and stainless steel.
9 . The medical device as defined in any one of claims 1 to 8 , wherein the plasma polymer layer is between 10 and 1000 nm thick, optionally between 100 and 500 nm thick.
10 . (canceled)
11 . The medical device as defined in claim, wherein the bactericide layer includes bioactive bacteriophages covalently bound to the plasma polymer layer, optionally a combination of both podoviridae and myoviridae in the same bactericide layer.
12 . The medical device as defined in claim 1 , wherein the bactericide layer includes bacteriophage related products covalently bound to the plasma polymer layer.
13 . The medical device as defined in claim 1 , wherein the bactericide layer includes a coating material covalently or electrostatically, or both covalently and electrostatically bound to the plasma polymer layer.
14 . (canceled)
15 . The medical device as defined in claim 1 , wherein the bactericide layer includes bioactive bacteriophages dispersed in a coating material, the coating material being bound to the plasma polymer, optionally wherein the coating material is a polymer defining an exposed surface, the bactericide layer defining microchannels extending in the coating material from the exposed surface, further optionally wherein the microchannels have a diameter of from about 5 nm to about 5 μm.
16 . The medical device as defined in claim 1 , wherein the bactericide layer includes bacteriophage related products dispersed in a coating material, the coating material being bound to the plasma polymer, optionally wherein the coating material is a polymer defining an exposed surface, the bactericide layer defining microchannels extending in the coating material from the exposed surface, further optionally wherein the microchannels have a diameter of from about 5 nm to about 5 μm.
17 . (canceled)
18 . (canceled)
19 . The medical device as defined in claim 15 , further comprising salt crystals embedded in the coating material.
20 . The medical device as defined in claim 19 , wherein the bacteriophages are adsorbed on the salt crystals.
21 . The medical device as defined in claim 19 , wherein the salt crystals include at least one of calcium salt crystals, magnesium salt crystals, strontium salt crystals, and barium salt crystals.
22 . The medical device as defined in claim 19 , wherein the salt crystals are between about 5 nm and about 5 μm in size.
23 . The medical device as defined in claim 15 , wherein the coating material is a block co-polymer.
24 . The medical device as defined in claim 1 , wherein the bactericide layer includes bacteriophage-containing biodegradable microcapsules bound to the plasma polymer.
25 . The medical device as defined in claim 1 , wherein the bactericide layer includes bacteriophage-containing biodegradable microcapsules embedded in a coating material, the coating material being bound to the plasma polymer, the bactericide layer optionally including bacteriophages dispersed thereinto outside of the microcapsules, optionally wherein the biodegradable microcapsules are made of a co-polymer.
26 . (canceled)
27 . (canceled)
28 . (canceled)
29 . The medical device as defined in claim 1 , wherein the medical device is selected from the group consisting of an orthopaedic implant, a stent, a catheter, and a defibrillator.
30 .- 72 . (canceled)
73 . A medical device, the medical device comprising:
a substrate defining a surface;
a bactericide layer sprayed on the surface, the bactericide layer containing microencapsulated bacteriophages.